Yazan Madanat, MD
Associate Professor
Specialities: Myelodysplastic Syndromes, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Spoken languages: English

Specialities: Myelodysplastic Syndromes, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Spoken languages: English
Yazan Madanat, M.D., is an Associate Professor of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. His clinical research interest lies in understanding the molecular and genomic drivers of disease and in better understanding ways to incorporate novel therapies for our patients.
Originally from Amman, Jordan, Dr. Madanat earned his medical degree at the University of Jordan and completed internal medicine residency training at the Cleveland Clinic. Then, drawn by the opportunity for harmonious integration of clinical medicine, pathophysiology of disease, and novel treatment approaches, he completed his hematology and medical oncology fellowship at the Cleveland Clinic with a clinical and research focus on myeloid malignancies; myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms (MDS/MPN), and acute myeloid leukemia.
Certified by the American Board of Internal Medicine, he joined the UT Southwestern faculty in 2019.
Dr. Madanat is a member of several professional organizations, including the American Society of Clinical Oncology, the American Society of Hematology, and the American College of Physicians. He earned Abstract Achievement Awards from the American Society of Hematology for two consecutive years (2017 and 2018) and received an honorable distinction award from the Society of Hematologic Oncology in 2018.
He has delivered several presentations and published numerous academic articles and book chapters that focus on the treatment of myeloid malignancies, acute leukemia, and myelodysplastic syndromes.
Harold C. Simmons Comprehensive Cancer Center - UT Southwestern: 5323 Harry Hines Blvd, Dallas, TX 75390, USA
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Together we care.
Together we cure.
3x Faster.